select trial semaglutide nejm Oral and Cardiovascular Outcomes in Type 2 Diabetes Beyond obesity: Novo's SELECT re-defines

Metformin is an oral medication that is gaining some traction, but like Ozempic, it is only FDA-approved to treat type 2 diabetes

Complimentary BTL VanquishME Session: An added perk to boost the effectiveness of the weight loss regimen

This delayed emptying also reduces the glucose spike that typically follows carbohydrate consumption

Relationship between oxidative stress and muscle mass loss in early postmenopause: an exploratory study

The prevalence of bullous pemphigoid was 0.0859% in total, with a trend toward a higher risk associated with vildagliptin use compared to the other DPP-4 inhibitors (51)

Weight-loss injections like Ozempic and Mounjaro are increasingly popular, but their effects in menopause such as potential muscle and bone loss, changes in hormone therapy absorption, to name a few, demand thoughtful, evidence-led discussion